Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.980,76
1,11%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SomaLogic Inc (SLGC) SomaLogic Inc (SLGC) Notizie

SLGC

SomaLogic (SLGC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SLGC
DataOraFonteTitoloSimboloCompagnia
16/01/202414:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SLGCSomaLogic Inc
12/01/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLGCSomaLogic Inc
10/01/202403:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLGCSomaLogic Inc
09/01/202423:16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SLGCSomaLogic Inc
05/01/202422:43Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SLGCSomaLogic Inc
05/01/202422:40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SLGCSomaLogic Inc
05/01/202422:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLGCSomaLogic Inc
05/01/202404:23GlobeNewswire Inc.Standard BioTools Stockholders Approve Merger with SomaLogicNASDAQ:SLGCSomaLogic Inc
05/01/202403:44PR Newswire (US)SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special MeetingNASDAQ:SLGCSomaLogic Inc
05/01/202400:57Business WireMadryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special MeetingNASDAQ:SLGCSomaLogic Inc
04/01/202420:23Business WireMadryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
03/01/202414:00Business WireProxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
02/01/202423:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLGCSomaLogic Inc
02/01/202414:00PR Newswire (US)SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
30/12/202301:10Business WireMadryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional DisclosuresNASDAQ:SLGCSomaLogic Inc
29/12/202322:42PR Newswire (US)Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
29/12/202314:42PR Newswire (US)SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All StockholdersNASDAQ:SLGCSomaLogic Inc
28/12/202322:16PR Newswire (US)Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
26/12/202323:11Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SLGCSomaLogic Inc
26/12/202321:59PR Newswire (US)SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading DisclosureNASDAQ:SLGCSomaLogic Inc
26/12/202315:15Business WireMadryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of AlternativesNASDAQ:SLGCSomaLogic Inc
24/12/202315:30Business WireMadryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
23/12/202302:00Business WireMadryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
23/12/202300:47GlobeNewswire Inc.ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
22/12/202314:30Business WireMadryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
21/12/202314:00GlobeNewswire Inc.SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
21/12/202313:30Business WireMadryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor PresentationNASDAQ:SLGCSomaLogic Inc
20/12/202315:00GlobeNewswire Inc.Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
18/12/202323:36Business WireMadryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
12/12/202323:31Business WireMadryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SLGC

La tua Cronologia

BIT
UC7Z1Z
Unicredit Bank
AMEX
SVIX
1x Short VIX Futures ETF
USOTC
RPHCF
Rohto Pharmaceutical (PK)
BIT
F34773
Vontobel Financial Produ...
LSE
ARB
Argo Blockchain
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network